Collectively, these data suggested that the YTHDF2 overexpression conferred TMZ resistance, promoted proliferation and restrained apoptosis of GBM cells, while YTHDF2 silencing exerted the adverse effects. This evidence concerns the gene YTHDF2 and glioblastoma.